Trial · NCT02495285
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Dosing of the Products During Surgery | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | ml/kg | MEAN | |
| SECONDARY | Potentia Hydrogenii | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for potentia hydrogenii were not entered for all partipants by the sites in the data collection form. | unitless | MEAN |
| SECONDARY | Hemoglobin | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for Hemoglobin were not entered for all participants by the sites in the data collection form. | mmol/L | MEAN |
| SECONDARY | Lactate | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for lactates were not entered for all participants by the sites in the data collection form. | mmol/l | MEAN |
| SECONDARY | Hematocrit | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for Hematocrit were not entered for all subjects by the sites in the data collection form. | % | MEAN |
| SECONDARY | Glucose | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for glucose were not entered for all participants by the sites in the data collection form | mmol/l | MEAN |
| SECONDARY | Serum Prolin | Before (0 - 2 days) and up to 2 days after infusion of gelatin solutions | Serum proline was only documented in four study participants in total. Not part of clinical routine. | µmol/l | MEAN |
| SECONDARY | Serum Creatinine | Before (0 - 2 days) and up to 2 days after infusion of gelatin solutions | The data for Serum Creatinine were not entered for all participants by the sites in the data collection form. | µmol/l | MEAN |
| SECONDARY | Number of Participants With (Serious) Adverse Events / Reactions | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Heart Rate | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for heart rate were not entered for all participants by the sites in the data collection form. | beats per minute | MEAN |
| SECONDARY | Mean Arterial Pressure | Before (0 - 2 h) and up to 2 h after infusion of gelatin solutions | The data for mean arterial pressure were not entered for all participants by the sites in the data collection form | mmHg | MEAN |
| SECONDARY | Follow-up Assessed by Number of Participants With Post-operative Complications | At discharge from the hospital or in-hospital 3 months after start of gelatine infusion, whatever occurs first. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02495285/outcomes